| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Charlie Bilello slams "absurd" gov't data claiming health insurance fell 18%. He says costs "only go in one dir...
Initiative Delivers Scalable Interoperability, Reduces Administrative Burden for Providers and PatientsHumana Inc. (NYSE:HUM) a...
Texas court rules against Humana, upholding Medicare Advantage bonus cuts and risking billions in insurer revenue tied to star ...
Wall Street edged higher Tuesday as strong bank earnings lifted sentiment, even as renewed U.S.-China trade tensions kept inves...
https://www.bloomberg.com/news/articles/2025-10-14/humana-loses-second-lawsuit-to-reverse-medicare-bonus-cuts
B of A Securities analyst Kevin Fischbeck maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $280 t...
Mizuho analyst Ann Hynes maintains Humana (NYSE:HUM) with a Outperform and raises the price target from $300 to $345.